Actively Recruiting
Cognitive and Fusion Prostatic Biopsy
Led by Menoufia University · Updated on 2026-01-05
80
Participants Needed
2
Research Sites
31 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to compare two different prostate biopsy techniques used to detect prostate cancer. These techniques are cognitive-targeted biopsy (CTB) and magnetic resonance imaging-ultrasound fusion-targeted transrectal biopsy (FTB). Both methods aim to improve the accuracy of prostate cancer detection by targeting suspicious areas identified on prostate imaging. This study will compare how accurately each technique detects prostate cancer, the pathological findings obtained from each biopsy method, and how operator performance may influence the procedure. The information gained from this study may help improve prostate cancer diagnosis and guide future biopsy practices.
CONDITIONS
Official Title
Cognitive and Fusion Prostatic Biopsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biopsy-na�efve patients
- Prostate-specific antigen level between 4 and 20 ng/mL
- Multiparametric Magnetic Resonance Imaging Prostate Imaging-Reporting and Data System score 4 or 5
You will not qualify if you...
- Prior prostate biopsy
- Prostate-specific Antigen level outside the specified range
- Contraindication to Magnetic Resonance Imaging
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Menoufia university hospital urology department
Shibīn al Kawm, Egypt
Not Yet Recruiting
2
Menoufia university hospital urology department
Shibīn al Kawm, Egypt
Actively Recruiting
Research Team
M
Mahmoud A Wahbah, MASTER
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SEQUENTIAL
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here